# HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer

> **NCT02523404** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 60 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **PROCEDURE:** interventional therapy

## Key facts

- **NCT ID:** NCT02523404
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02523404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02523404, "HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02523404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*